United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules, usp are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. extended phenytoin sodium capsules are contraindicated in patients with: - a history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins [see warnings and precautions (5.5)] . reactions have included angioedema. - a history of prior acute hepatotoxicity attributable to phenytoin [see warnings and precautions (5.8)]. - coadministration with delavirdine because of the potential for loss of virologic response and possible resistance to delavirdine or to the class of non-nucleoside reverse transcriptase inhibitors. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as extended phenytoin sodium capsules, during pregnancy. physicians are advised to recommend that pr

Kenya - English - Pharmacy and Poisons Board

phenytoin sodium - tablet - each tablet contains phenytoin sodium 100mg - phenytoin

Kenya - English - Pharmacy and Poisons Board

phenytoine 250mg/5ml - injection - phenytoine 250mg/5ml - antibacterials for systemic use

Canada - English - Health Canada

aa pharma inc - phenytoin sodium - capsule - 100mg - phenytoin sodium 100mg - hydantoins

Canada - English - Health Canada

sandoz canada incorporated - phenytoin sodium - liquid - 50mg - phenytoin sodium 50mg - hydantoins

Canada - English - Health Canada

hikma canada limited - phenytoin sodium - solution - 50mg - phenytoin sodium 50mg - hydantoins

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - phenytoin sodium - oral capsule - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - phenytoin sodium - oral capsule - 100mg

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - phenytoin sodium - solution for injection/infusion - 250 mg/5ml - hydantoin derivatives; phenytoin

United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - phenytoin (unii: 6158tkw0c5) (phenytoin - unii:6158tkw0c5) - phenytoin 125 mg in 5 ml - phenytoin oral suspension is indicated for the control of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see and sections). dosage and administration clinical pharmacology phenytoin oral suspension is contraindicated in those patients with a history of hypersensitivity to phenytoin or other hydantoins. serum concentrations should be monitored and care should be taken when switching a patient from the sodium salt to the free acid form. the free acid form of phenytoin is used in phenytoin oral suspension. because there is approximately an 8% increase in drug content with the free acid form over that of the sodium salt, dosage adjustments and serum level monitoring may be necessary when switching from a product formulated with the free acid to a product formulated with the sodium salt and vice versa. dosage should be individualized to provide maximum benefit. in some cases serum b